U.S. District Judge Jon S. Tigar entered a judgment for ChemoCentryx Inc. on Aug. 15, writing that all of the statements the shareholder plaintiff had alleged were false or misleading were opinions ...

Shares of Rocket Pharmaceuticals RCKT surged 28.9% yesterday, after the FDA lifted the clinical hold on the pivotal phase II study evaluating its investigational gene therapy candidate, RP-A501, for ...